BACM
ZBH icon

Blue Arrow Capital Management’s Zimmer Biomet ZBH Stock Holding History

Blue Arrow Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-45,382
Closed -$4.78M – 244
2014
Q3 		$4.43M Buy
45,382
+35,185
+345% +$3.46M 0.48% 74
2014
Q2 		$1.03M Buy
+10,197
New +$995K 0.14% 110

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Blue Arrow Capital Management's ZBH Position: Q4 2014 in Review

Blue Arrow Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2014, closing a stake of 45,382 shares — an estimated $4.78M sold.

Blue Arrow Capital Management first reported a position in ZBH in Q2 2014 and held it in 2 quarters. The position peaked at $4.43M in Q3 2014. 750 funds tracked by Wall St. Rank hold ZBH as of Q4 2014.

  • Blue Arrow Capital Management reported no remaining Zimmer Biomet position as of Q4 2014 after selling out during the quarter.
  • Blue Arrow Capital Management sold 45,382 Zimmer Biomet shares in Q4 2014, an estimated $4.78M.
  • Blue Arrow Capital Management first reported a position in Zimmer Biomet in Q2 2014 and held it in 2 quarters.
  • Blue Arrow Capital Management's Zimmer Biomet position peaked at $4.43M in Q3 2014.
  • 750 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2014.

Based on Blue Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.